Product Images Vyleesi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 19 images provide visual information about the product associated with Vyleesi NDC 64011-701 by Amag Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure-1 - vyleesi 01

figure-1 - vyleesi 01

This appears to be a list of drugs and their corresponding Cmax values in pharmacokinetics.*

label - vyleesi 02

label - vyleesi 02

Not available.*

label - vyleesi 03

label - vyleesi 03

figure-1 - vyleesi 04

figure-1 - vyleesi 04

The text provides instructions for the use of Vyleesi, which is an injection containing bremelanotide with a strength of 175mg/0.3ml. The medication is intended for subcutaneous use only.*

figure-2 - vyleesi 05

figure-2 - vyleesi 05

This text is a description of the different parts of an autoinjector. The autoinjector has a clear view window with a gray tip which indicates when the autoinjector is ready for use. It also has a purple window which indicates when the injection is complete. The expiration date of the autoinjector is also mentioned.*

figure-3 - vyleesi 06

figure-3 - vyleesi 06

Vyleesi is a medication whose pronunciation is "vahy-lee-see". Unfortunately, no further information was provided about its purpose or characteristics.*

figure-4 - vyleesi 07

figure-4 - vyleesi 07

figure-5 - vyleesi 08

figure-5 - vyleesi 08

figure-6 - vyleesi 09

figure-6 - vyleesi 09

figure-7 - vyleesi 10

figure-7 - vyleesi 10

figure-8 - vyleesi 11

figure-8 - vyleesi 11

figure-9 - vyleesi 12

figure-9 - vyleesi 12

figure-10 - vyleesi 13

figure-10 - vyleesi 13

figure-11 - vyleesi 14

figure-11 - vyleesi 14

figure-12 - vyleesi 15

figure-12 - vyleesi 15

figure-13 - vyleesi 16

figure-13 - vyleesi 16

carton - vyleesi 17

carton - vyleesi 17

This is a description for a drug called Vvleesi, which contains Bremelanotide as the active ingredient. It is an injection for subcutaneous use only and comes in a 175mg/0.3mL dosage. The inactive ingredients in the drug include 2.5% glycerin in water and HCL or NaOH to adjust pH. It is manufactured for AMAG Pharmaceuticals and has an expiration date. There are specific instructions not to use the drug beyond a certain date, and for any questions, one can call customer service at 1-877-411-2510.*

label - vyleesi 18

label - vyleesi 18

This text provides information about a medication called "vyleesi" which is an injection of bremelanotide. It contains 175mg/0.3mL for subcutaneous use only and is manufactured for AMAG Pharmaceuticals, Inc. The medication is available in a single-dose autoinjector, and it is recommended to take no more than 1 dose in 24 hours, or 8 doses per month. The NDC number of the medication is 6401170101, and it should be stored at or below 25°C (77°F) and protected from light.*

vyleesi 19

vyleesi 19

This is a medication called Vyleesi, which is an injection containing the active ingredient Bremelanotide used for subcutaneous use under the supervision and prescription of a licensed healthcare professional. The medication should not be used beyond the expiration date mentioned on the product's packaging. For any questions or concerns, consumers can call the phone number: 1-877-411-2510. The manufacturer is AMAG Pharmaceuticals Inc., based in Waltham, MA. The output includes several product codes and random characters, which are illegible and have no meaning in this context.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.